The increase in basophils in CML patients, despite the inhibition of IRF8 by BCR-ABL, is contrary to the phenotype seen in IRF8–/– mice, which display a severe reduction in basophil counts52. This evidence concerns the gene IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive.